February 20, 2008 file: s250

Administrative Bylaws
Including Drug Schedules I and II
Table of Contents - SCP Administrative Bylaws

1.0 Title………………………………………………………………………………………… 1
2.0 Definitions………………………………………………………………………………… 1
3.0 Council………………………………………. … 1
Constitution and Election……………………………………………………. 4.0 Council
Meetings……………………………………………………… . ……………… 2
Officers and Duties of Officers and Council………………………………………. 3
President………………………………………………………………….…… President-Elect………………………………………………………………… Registrar-Treasurer…………………………………………………………… Committees……………………………………………………………………. Continuing Education or Continuing Professional Development………… Auditor…………………………………………………………………………. Grants, Contributions or Other Payments to
PAS (formerly RBSP) or Others………… . 5
7.0 Meetings…………………………………………………………………………………. 5
8.0 Fiscal
Year…………. ……………………………………………………….………… 6
Fees (Registration, Membership. Licence and Reinstatement Fees)……… . 6
Second Pre-Opening inspection…………………………………………… Lock and Leave………………………………………………………….……. 11.0 Miscellaneous……………………………………………………………………………. 7
12.0 Miscellaneous……………………………………………………………………………. 7
13.0 Miscellaneous……………………………………………………………………………. 7

DRUG SCHEDULES I and II
Schedule I - Prescription Drugs………………………………………………………………. 1
Schedule II - Restricted Access Non-Prescription Drugs………………………….……… 5
Index - By Subject
SCP Administrative Bylaws
Section #
Constitution and Election of Council . 3.0 Grants, Contributions or other Payments to the Pharmacists Association of Saskatchewan. Officers and Duties of Officers and Council . Second pre-opening inspection Fees. 10.1(c) DRUG SCHEDULES I and II
Schedule I - Prescription Drugs
Schedule II - Restricted Access Non-Prescription Drugs
Administrative Bylaws of the Saskatchewan College of Pharmacists
These bylaws may be referred to as The Administrative Bylaws of the Saskatchewan College of Pharmacists or SCP Administrative Bylaws. Definitions
(a) “Act” means The Pharmacy Act, 1996
(b) “College” means the Saskatchewan College of Pharmacists.
(c) “Continuing professional development” includes any continuing education, continuing
professional development or competency assurance requirements, or any relevant program thereto that
Council may prescribe from time to time as a condition for practising members to maintain or renew their
licence.
(d) “Practice” means providing direct patient care as a pharmacist, and includes, but is not limited to
dispensing, compounding or selling drugs, advising patients, or supervising pharmacists who provide
direct patient care, and “practising” has a similar meaning.
Constitution and Election
3(1) Council shall consist of one practising or non-practising member duly elected or appointed from each of
eight electoral divisions, plus the President, President-elect and Vice-president and those specified in sections
7(2)(b), (c) and (d) of the Act.
(2) Unless a bylaw provides otherwise, the term of an elected member of Council shall be for two years beginning July 1. (3) The province shall be divided into eight electoral divisions described as follows: Electoral Division No. 1 being that portion of the province of Saskatchewan bounded on the South by the International Boundary line, on the East by the easterly boundary of the province; on the North by the northerly boundary of township twenty-four; and on the West by the westerly boundary of range twenty-one west of the second principal meridian but excluding the city of Regina and the area within five miles of the city limits. Electoral Division No. 2 being that portion of the province bounded on the South by the southerly boundary of township twenty-five; on the East by the easterly boundary of the province; on the North by the northerly boundary of the province; and on the West by the westerly boundary of range twenty-one west of the second principal meridian. Electoral Division No. 3 being that portion of the province bounded on the South by the southerly boundary of township forty-two; on the East by the easterly boundary of range twenty-two west of the second principal meridian; on the North by the northerly boundary of the province; and on the West by the westerly boundary of the province. Electoral Division No. 4 being that portion of the province within the city of Saskatoon and any area within five miles of the city limits of Saskatoon. Electoral Division No. 5 being that portion of the province within the city of Regina and any area within five miles of the city limits of Regina. Electoral Division No. 6 being that portion of the province bounded on the South by the International Boundary line; on the East by the easterly boundary of range twenty-two west of the second principal meridian; on the North by the northerly boundary of township twenty-one; and on the West by the westerly boundary of the province. Electoral Division No. 7 being that portion of the province bounded on the South by the southerly boundary of township twenty-two; on the East by the easterly boundary of range twenty-two west of the second meridian; on the North by the northerly boundary of township forty-one but excluding the city of Saskatoon; and the area within five miles of the city limits of Saskatoon; and on the West by the westerly boundary of the province. Electoral Division No. 8 shall include every practising member who practises as a hospital pharmacist, and every non-practising member who was practising as a hospital pharmacist prior to becoming a non-practising member. Administrative Bylaws of the Saskatchewan College of Pharmacists
(4) The charge and conduct of the elections shall be under the management of the Registrar who shall be the returning officer. (5) Elections will be held on the fourth Wednesday in March. Except in electoral divisions from which Council has chosen the President, Vice-president or President-elect or as otherwise directed by Council, election of Councillors in Divisions 1, 3, 5 & 7 will be held during odd numbered years while election of Councillors in Division 2, 4, 6 & 8 will be held during even numbered years. (6) Every practising or non-practising member resident in Saskatchewan is, at an election of members of the Council, entitled to vote for a candidate for the electoral division in which the practising member practices or the non-practising member resides on the day when the notice of election is mailed. (7) Except in electoral divisions from which Council has chosen the President, Vice-president or President-elect or as otherwise directed by Council, the Registrar shall mail, at least two months prior to the date of the election to each practising or non-practising member qualified to vote thereat, notice of the Council election date. (8) Every practising or non-practising member resident in Saskatchewan is eligible to be elected a member of the Council for the electoral division in which the practising member actively practises or in which the non-practising member resides on the day when the notice of election is mailed, by mailing or delivering to the Registrar a written nomination signed by three other members eligible to vote in the division. The nomination shall be accompanied by the acceptance in writing of the nominee, and to be valid must be received by the Registrar not later than 30 days prior to the date of the election. (9) Any practising member may nominate not more than one candidate for the division in which he practises, or non-practising member may nominate not more than one candidate for the division in which he resides. (10) When only one nomination is received from any Division within thirty (30) days of the date fixed for the election, the member nominated shall be declared elected. (11) Except in electoral divisions from which Council has chosen the President, Vice-president or President-elect or as otherwise directed by Council, the Registrar shall mail ballots and ballot envelopes to every practising or non-practising member who is entitled to vote at least 20 days prior to the day of the election. The outer ballot envelope shall bear a statement signed by the practising or non-practising member that he is entitled to vote in his electoral division. Each ballot shall be mailed or delivered directly to the Registrar, by the voter in an individual sealed envelope marked “ballot”. (12) The Registrar shall appoint two practising or non-practising members as scrutineers to count the ballots. Any member is entitled to be present at the counting of the ballots. (13) The Registrar shall retain all ballots received until 10:00 a.m. of the day of the election, when the same shall be opened at the office of the Registrar in the presence of the scrutineers. (14) In each electoral division the practising or non-practising member who receives the highest number of votes shall be declared elected as a member of Council. (15) Where, by reason of an equality of votes for two or more practising or non-practising members in an electoral division, the election of a member is undecided, the Registrar shall, in the presence of the scrutineers, draw by chance the name of the practising or non-practising member deemed to be duly elected. (16) Where, for any reason, a vacancy occurs or a practising or non-practising member is not elected to the Council for an electoral division, the remaining members of the Council may appoint as a member of the Council for the unexpired portion of the term, a practising or non-practising member who meets the qualifications specified in subsection (8). Without limiting the generality of the foregoing a vacancy in an electoral division for the corresponding term occurs when the Councillor elected or appointed to that division is chosen to be the President, President-elect or Vice-president. Upon failure to appoint a member who meets the qualifications specified in subsection (8), Council may then appoint as a member of the Council for the unexpired portion of the term a practising or non-practising member from the membership at large. Meetings
4(1) Council shall meet at least once per year, and more frequently as needed at times and locations at their
call, or at the call of the President upon giving at least 14 days notice of the time and location to each of the
Administrative Bylaws of the Saskatchewan College of Pharmacists
members of Council. Notwithstanding the foregoing, any four members of the Council for sufficient reasons may cause a meeting of Council to be held upon giving a like notice in writing of the purpose for which the meeting is to be held. Subject to the Act and these bylaws, Council and each of its committees, including without limitation the Complaints Committee and Discipline Committee, may convene in person or via telephone or other communications facilities as permit all persons participating in the meeting to hear one another, and any person participating in such meeting by such means is deemed to be present at the meeting. Council, and each of its committees, including without limitation the Complaints Committee and Discipline Committee, shall convene at the location, or in the manner, as the Committee Chair or his/her designate determines is appropriate or, in the absence of such specific designation, at the offices of the College. A majority of the members of Council constitute a quorum at a meeting of Council. Unless specified otherwise in the Act or bylaws, a decision by a majority of members of Council participating in a meeting shall be deemed a decision of Council. A resolution in writing, signed by all members of Council or all the members of any committee of Council, including without limitation the Complaints Committee and Discipline Committee, as the case may be: is as valid as if it had been passed at a meeting of the Council or Committee; satisfies all of the requirements relating to a meeting of the Council or Committee; and is effective for all purposes at such time as the resolution states regardless of when the resolution is signed and may be signed in counterpart. At all Council meetings, unless the Chairman shall otherwise order, the order of business shall be as follows: approval of the minutes of the last meeting; Members of Council present at each meeting shall be eligible to receive income replacement to a maximum of $210.00 per day and a meal allowance of $105.00 per day for days actually spent in going to and from, and actually attending such meetings. In addition thereto, Council shall be eligible to receive travel allowance and hotel and other related expenses. Officers and Duties of Officers and Council
5(1) Officers of the College shall include the President, President-Elect, Vice-President, and the Registrar and
the Treasurer or the Registrar Treasurer (hereinafter referred to as the Registrar-Treasurer). The Officers shall
act upon all matters delegated to them by the Council, including, but not limited to the execution of documents,
and officially representing SCP subject to Council policy. Other than provided in subsection (3), documents
shall be executed by at least one of the President, President-Elect or Vice-President, and the Registrar-
Treasurer or his designate.
Council shall, at its first meeting after the election, or as soon thereafter as may be convenient, choose from amongst its members a President, President-Elect and Vice-President for a one-year term, which may not be renewed except in unusual circumstances, to begin on the first day of July of each year. The officers shall continue to act until Council chooses their successors. The Registrar-Treasurer shall make all payments on behalf of the College by cheque and the cheques in the amount of $5,000.00 or less shall be signed by the Registrar-Treasurer, or, in his absence, by the Assistant Registrar or the Field Officer, and the cheques exceeding the amount of $5,000.00 shall be signed by the Registrar-Treasurer, or, in his absence, by the Assistant Registrar or the Field Officer, and by either the President, President-Elect or the Vice-President. Administrative Bylaws of the Saskatchewan College of Pharmacists
Council may appoint employees, inspectors and agents, as it may deem necessary to carry out preside at all meetings of the Council and of the College, regulate the order thereof, decide as to what question is in order, and receive and put all motions, except motions of adjournment, to a vote; sign all certificates and other instruments or documents executed on behalf of the College, except present a report to the annual meeting of the College; be, ex-officio, a member of all committees; consult with the Registrar respecting any urgent business that may arise between meetings of have charge of all bonds given as security by the officers for the discharge of their duties; and exercise a general supervision over the affairs of the College. The President-Elect shall perform the duties of the President in his absence, and in the absence of both, the Vice-President shall perform the duties of the President, if for any reason the President cannot continue to hold office, the President-Elect shall become President and the Vice-President shall become President-Elect, and in such case Council shall choose from its members a new Vice-President to hold office until the time of a new election. Council shall at its first meeting after the election, or as soon thereafter as may be convenient, appoint a Registrar-Treasurer. The Registrar-Treasurer need not be a member either of the Council or of the College and shall perform the duties herein prescribed and such other duties as may be assigned to him by the Council; pursuant to section 16 of the Act, keep the registers of members, interns and proprietary pursuant to section 21 of the Act, register persons as members, register persons as interns, issue licences to members, and issue or amend permits for proprietary pharmacies; be Secretary of the College, and shall keep and record all minutes of the meetings of the Council, and of the College. He shall conduct the correspondence, and issue all notices, certificates, licences and permits; be the Treasurer and take charge of the funds of the College, and also keep a set of financial accounts, which will be open to the inspection of the Council or any members thereof. At each meeting of the Council he shall present an interim financial statement and at each annual meeting of the College he shall present an audited financial statement. He shall deposit all funds received by, or payable to the College, in a chartered bank to be selected by the Council; be required to furnish a bond or bonds for the satisfactory performance of his duties for $4,000.00, premium for which shall be paid out of the funds of the College; superintend the affairs of the College under the direction of the Council; and (vii) visit and inspect from time to time proprietary pharmacies in the province, in order to ascertain if each is conducted in conformity with the provisions of the Act, bylaws and any other requirements of Council. He may delegate such visits and inspections to employees of the College. In his absence or his inability to act, a person appointed by the Council may make such visit and the inspection. If the office of Registrar-Treasurer becomes vacant by reason of death, resignation or otherwise, the Council shall appoint a suitable person to act as Registrar-Treasurer until they are able to appoint a Administrative Bylaws of the Saskatchewan College of Pharmacists
successor. He shall perform all the duties of the Registrar-Treasurer and shall have such other powers and perform such other duties as may from time to time be assigned to him by Council. The Council may appoint such standing committees or temporary committees as may be necessary for any purpose. Each committee may include members of Council and other voting members of the College. The President shall be, ex-officio, a member of each committee. Terms of reference shall be developed by Council. Continuing Education or Continuing Professional Development The Council shall from time to time set the continuing education or continuing professional development requirements for the issuing of a licence. At its regular annual meeting, the Council shall appoint one Auditor, who shall be a chartered accountant, whose duties shall be to examine all accounts connected with the College, and all books in the custody of the Registrar-Treasurer, to examine and compare all vouchers, to actually inspect all securities owned by the College, to certify to the correctness of the Annual Balance Sheet, and to finish a written report, which shall be presented at the Annual General Meeting of the College each year. Grants, Contributions or other Payments to the Pharmacists’ Association of Saskatchewan (formerly the
Representative Board of Saskatchewan Pharmacists Inc.) and others
6(1) Council is authorized, by way of ordinary resolution, to make grants, contributions or other payments to the
Pharmacists Association of Saskatchewan (formerly the Representative Board of Saskatchewan Pharmacists Inc.)
or similar organization for any purpose that is consistent with the objectives of the College including, without limiting
the generality of the foregoing, the operation, funding or administration of a program to provide compensation to
pharmacies or pharmacists for professional services that are not compensated for pursuant to The Prescription
Drugs Act.
“Check-off Funds” means the funds held by the Minister in the Unconditional Receipt Account representing amounts which proprietary pharmacies directed be withheld by the Minister and paid to the College in accordance with written agreements between the Minister and such proprietary pharmacies pursuant to section 5 of The Prescription Drugs Act. “Minister” means the Government of Saskatchewan, as represented by the Minister of Health. “Unconditional Receipt Account” means the account established pursuant to section 3.1 of the written agreement between the Minister and the College dated April 2, 1996 wherein the remaining Check-off Funds are deposited. The College is specifically authorized to take all necessary steps to transfer all of its right, title and interest in the Check-off Funds remaining in the Unconditional Receipt Account to the Pharmacists’ Association of Saskatchewan ( formerly the Representative Board of Saskatchewan Pharmacists Inc.), provided that any such transfer shall be subject to, among other things: a contractual restriction that the transferred Check-off Funds be used by the Pharmacists’ Association of Saskatchewan exclusively for the operation, funding or administration of a program to provide compensation to pharmacies or pharmacists for professional services that are not compensated pursuant to The Prescription Drugs Act; and such other terms and conditions as the Council deems appropriate. This paragraph (b) of subsection (2) of Bylaw 6 shall expire upon the consummation of the transactions contemplated by subsection (1) or December 31, 2005, whichever is later. Meetings
7(1) Notice of every meeting of the College shall be given to each of the members thereof, by mail, at least 14
days before such meeting is held. Each notice so given shall state the purpose for which the meeting is called,
and in the event of the Registrar-Treasurer having received previous notice in writing affecting the amending,
Administrative Bylaws of the Saskatchewan College of Pharmacists
alteration, or repealing of these bylaws in whole or in part, particulars of such amendment, alteration, or repeal shall be contained in such notice. (2) All notices required under the provisions of the Act or these bylaws shall be sent to the address contained in the Register of the College. (3) The meetings of the College shall be held in such place in Saskatchewan as the College at its previous meeting shall select or at a place to be selected by the Council. (4) Pursuant to Section 6(3)(b) of the Act, a request for a special general meeting of the College shall be made in writing to the Registrar by at least 10% of pharmacists. (5) At all meetings of the College, the vote of the majority of pharmacists present shall be conclusive upon all matters brought before the meeting, and the chair shall not vote except in the case of an equality of votes when he shall have a casting vote. (6) Thirty pharmacists shall constitute a quorum for the transaction of business at a meeting of the College. (7) Only pharmacists are entitled to vote at a meeting of the College. At all Annual Meetings of the College the order of business shall be as follows: approval of the minutes of the last annual and general meeting; Registrar-Treasurer’s annual report and financial statement; Fiscal Year
8(1) The fiscal year of the College shall commence on the first day of January and end on the last day of
December during the same year.
Registration, Membership, Licence and Reinstatement Fees
9(1) The following fees shall be payable to the College. The membership and licence year shall be from July
1 to June 30 and fees are payable in advance:
on registration as a member having been an intern $270.00; on registration as a member, being a physician and surgeon in good standing in the College of Physicians and Surgeons of the province $820.00; on registration as a locum tenens for a member who is a physician $270.00; or on registration as a member from a jurisdiction other than Saskatchewan $715.00. The following fees apply to renewal of memberships and licences effective for one year beginning July 1. These renewal fees are payable in whole, or in part together with any applicable additional payments according to Council policy, and shall be delivered to the office of the Registrar-Treasurer on or before the first day of June in each year. Fees for new memberships and licences are based on the following, and are payable in advance in whole, or in part together with any applicable additional payments according to Council policy, and become effective upon approval of the Registrar-Treasurer for a period of time according to Council policy: Administrative Bylaws of the Saskatchewan College of Pharmacists
the applicant for a practising membership who does not deliver the prescribed fee to the Office of the Registrar-Treasurer on or before June 1 in each year, or who is not otherwise eligible for practising membership renewal, shall be assessed, in addition to the fee otherwise payable, a surcharge in the amount of $205.00; 10(1) Proprietary Pharmacy Permit Fees
fees shall be payable to the College. The permit year shall be from December 1 to November 30 the following fees apply to permit renewals effective for one year beginning December 1. These renewal fees are payable in whole, or in part together with any applicable additional payments according to Council policy, and shall be delivered to the office of the Registrar-Treasurer on or before the first day of November in each year. Fees for renewal or new permits are based on the following, and are payable in advance in whole or in part together with any applicable additional payments according to Council policy and remitted to the office of the Registrar-Treasurer. New permits become effective upon approval of the Registrar-Treasurer for a period of time according to Council policy; fees for a proprietary pharmacy permit issued to a proprietor - $1,700.00, or, for a proprietary pharmacy permit issued to a proprietor to operate an international prescription service pharmacy or internet pharmacy as expressly approved pursuant to SCP Regulatory Bylaw 4.6.1(b) in accordance with the policy and standards of Council as may be amended from time to time - $14,500.00; fee for a satellite proprietary pharmacy permit issued to a proprietor - $850.00; fee for the amendment of a proprietary pharmacy permit - $250.00; the applicant for any permit who does not deliver the prescribed fee to the Office of the Registrar-Treasurer on or before November 1 in each year, or who is not otherwise eligible for permit renewal, shall be assessed, in addition to the fee otherwise payable, a surcharge in the amount of $205.00; pharmacy permit reinstatement fee - $270.00; second pre-opening inspection, and for each pre-opening inspection thereafter - $500.00; Lock and Leave application fee - $435.00. MISCELLANEOUS
Service of any notice or documents required by these bylaws may be affected by registered letter addressed to the last known place of abode or business of the person to be served as the same appears on the register. Notice of any proposed amendments, alterations, or repealing of any of these bylaws at an Annual Meeting of the College shall be in writing, and delivered to the Registrar-Treasurer, 30 days prior to the date of the meeting. No motion of such amendment shall be considered at any meeting unless such notice has been duly given. In all bylaws of the Saskatchewan College of Pharmacists the singular shall include the plural and the plural the singular and the masculine shall include the feminine. Drug Schedules
I & II
Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
Schedule I drugs may only be sold by a pharmacist to the public for human use pursuant to a
prescription. They include those drugs described in clauses 2(2)(a) to (c) of The Drug Schedules
Regulations, 1997, and the following:
Alverine and its salts (for parenteral use) Amino Acid solutions (for parenteral use) Aminopromazine [proquamezine] and its salts Bacitracin and its salts and derivatives (for parenteral use) Calcium chloride in injectable form for parenteral nutrition Calcium gluconate in injectable form for parental nutrition Chromium Chloride (chromic chloride) in injectable form for parenteral nutrition Copper chloride (cupric chloride) in injectable form for parenteral nutrition Dextrose injection concentrated solutions for parenteral injection Ephedrine and its salts (in preparations containing more than 8 mg per unit dose, or with a label recommending more than 8 mg/dose or 32 mg/day, or labelled or implied for use exceeding 7 days, or if indicated for other than nasal congestion) Epinephrine and its salts (other than in pre-filled syringes intended for emergency administration by injection in the event of anaphylactic reactions to allergens) Famotidine and its salts, except when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn Fluoride and its salts (in solid oral dosage forms containing more than 1mg of fluoride ion) Folic acid (preparations containing more than 1 mg per recommended daily dose) Homatropine and its salts (for ophthalmic or parenteral use or in preparations for oral use containing more than 2mg per dosage unit) Ibuprofen and its salts (except when sold for oral administration in a concentration of 400 mg or less per dosage unit) Immune globulin products (this includes Cytomegalovirus immune globulins; Hepatitis B immune globulin; Rabies immune globulin; Rho D immune globulin; Tetanus immune globulin; and Varicella Zoster immune globulin) Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
Lipid solutions in injectable form for parenteral nutrition Magnesium sulfate in injectable form for parenteral nutrition Manganese and its salts in injectable form for parenteral nutrition Minoxidil (except in solutions for topical use in concentrations of 2% or less) Nicotine and its salts (except in natural substances, or when sold as a chewing gum containing not more than the equivalent of 4 mg of nicotine per dosage unit, or when sold in transdermal patches with delivery rates of 22 mg per day or less, or when sold in a form to be administered orally by means of an inhalation device delivering 4 mg or less of nicotine per dosage unit). Nitroglycerine (except for sublingual immediate release dosage forms) Nizatidine and its salts (except when sold in an oral dosage form containing not more than the equivalent of 75 mg of nizatidine Nizatidine and its salts (when sold in an oral dosage from containing not more than the equivalent of 75 mg of nizatidine) Nystatin and its salts and derivatives (except preparations for topical use on the skin) Pancreatic enzymes (in products for the treatment of established pancreatic insufficiency) Pancreatin (in products for the treatment of established pancreatic insufficiency) Pancrelipase (in products for the treatment of established pancreatic insufficiency) Potassium salts (in preparations for administration by injection) Proquamezine [aminopromazine] and its salts (for internal use) Ranitidine and its salts, except when sold in concentrations of 150 mg or less per oral dosage unit and indicated for the treatment of heartburn Selenium in injectable form for parenteral nutrition Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
Sodium acetate in injectable form for parenteral nutrition Sodium chloride in injectable form for parenteral nutrition Sodium iodine in injectable form for parenteral nutrition Sodium phosphate in injectable form for parenteral nutrition Vaccines (except for - those which are a part of a routine immunization program in most/all provinces and territories: Diphtheria toxoid, Tetanus toxoid, Pertussis, Poliomyelitis, Haemophilus influenzae type B., Measles, Mumps, Pneumococcus, Rubella, Hepatitis B. Pediatric, Influenza, cholera vaccine (oral, inactivated) when used for prophylaxis against travelers diarrhea and due to enterotoxigenic escherichia coli (ETEC); and those requiring special enhanced public access due to disease outbreaks: Meningococcus). Vitamin A in preparations containing more than 10,000 IU per recommended daily dose (Retinol) Vitamin D in preparations containing more than 1,000 IU per recommended daily dose Vitamin K except Vitamin K1 and Vitamin K2 sold a) for external use in humans; or b) in an oral dosage form for use in humans if the maximum recommended daily dose is 0.120 mg or Vitamins in injectable form for parenteral nutrition Zinc chloride in injectable form for parenteral nutrition Zinc sulfate in injectable form for parenteral nutrition Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
Schedule II - Restricted Access Non-Prescription Drugs The following drugs may be sold by a pharmacist to the public without a prescription. These
drugs must, at all times, be kept or stored in a secure location in the pharmacy, such as the
dispensary, that is not accessible to the public. The pharmacist must be involved in the sale of these
drugs, which includes arriving at the decision to sell the drug:
Acetylsalicylic acid and its salts (oral preparations containing 80 mg or less per dosage unit and intended for paediatric use or rectal preparations containing 150 mg or less per dosage unit, in package sizes containing no more than 1.92 g of acetylsalicylic acid ) Adiphene and its salts for parenteral use Amylocaine and its salts (for ophthalmic or parenteral use) Artemisia, its preparations, extracts and compounds (except in trace amounts in homeopathic preparations) Belladonna alkaloids and their salts and derivatives (except in preparations for topical use or in trace amounts in homeopathic preparations) Benoxinate hydrochloride (oxybuprocaine) for ophthalmic or parenteral use Benzalkonium and its salts (liquid preparations in concentrations of more than 2%) Benzethonium chloride (liquid preparations in concentrations of more than 1%) Benzocaine and its salts (for parenteral or ophthalmic use) Boric acid and its salts (in preparations for systemic use, or ophthalmic preparations in concentrations over 2%) [Note: does not apply to contact lens solutions intended to be rinsed off prior to insertion into the eye]. Bupivacaine and its salts for parenteral or ophthalmic use Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
Butacaine and its salts (for ophthalmic or parenteral use) Camphor (in oleaginous vehicles and in liquid forms in concentrations greater than 11%) Cantharides, their preparations and derivatives Charcoal (activated) for use in poisoning treatment Chloroprocaine and its salts (for parenteral or ophthalmic use) Chymotrypsin (parenteral and ophthalmic) Cinchocaine (dibucaine) and its salts (for ophthalmic or parenteral use) December/06 Clobetasone butyrate 0.05% in a cream formulation for topical use on the skin Coal tar (in concentrations of more than 10%) Codeine and its salts (in preparations exempted from the Regulations to the Controlled Drugs and Substances Act) Cyclomethacaine and its salts (for ophthalmic or parenteral use) Cyclopentolate and its salts (except for ophthalmic and parenteral use) Dicyclomine and its salts (except for topical use and lozenges) Dihydroquinidine and its salts (except phenylbarbiturate) Dimenhydrinate and its salts (for parenteral use) Diperodon and its salts (except for topical use) December/06 Diphenhydramine and its salts and preparations (for parenteral use) December/06 Diphenhydramine and its salts and preparations (for topical use in concentrations of greater than 2%) Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
Dyclonine (except for topical use on mucous membranes) Epinephrine and its salts (in pre-filled syringes intended for emergency administration by injection in the event of anaphylactic reactions to allergens) Ethyl chloride (except in trace amounts) Gentian Violet (for application to skin or mucous membranes) Heparin and its salts (except for topical use) Histamine and its salts (except for topical use) Homatropine and its salts (for oral use in concentrations of 2mg or less per dosage unit) Hyaluronic acid and its salts (preparations in concentrations of 5% or more) Hyoscine and its salts and derivatives [scopolamine] Hyoscyamine and its salts and derivatives (except for topical use) Iodine and its salts and derivatives (except topical preparations or in oral doses of 1 mg or less per day) Ipecac and its extracts and derivatives (when used as an emetic) Iron and its salts and derivatives (in preparations with more than 30mg elemental iron per solid dosage unit or 5 ml oral liquid) Levonorgestrel (when sold in concentrations of 0.75 mg per oral dosage unit) Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
December/06 Lidocaine and its salts (for ophthalmic or parenteral use, or topical use on mucous membranes, except
Loperamide and its salts in products marketed for paediatric use – under 12 years of age Mepivacaine and its salts (for ophthalmic or parenteral use) Methenamine and its salts (except for topical use) Methyl salicylate (liquid dosage forms in concentrations greater than 30%) Naphazoline and its salts (in nasal preparations for paediatric use) Naproxen sodium 220 mg tablet (when sold in products labelled with a recommended maximum daily dose of 440 mg and, in package sizes exceeding 6,600 mg) Niacin (in extended-release formulations) (nicotinic acid) Nicotinic acid, when sold in a modified-release oral dosage form providing less than 500 mg per dosage unit or per daily use Nitroglycerine (sublingual immediate release dosage forms) Nizatidine and its salts (except when sold in an oral dosage form containing not more than the equivalent of 75 mg of nizatidine Norepinephrine and its salts (levarterenol, noradrenalin) Oxybuprocaine and its salts (benoxinate) (for ophthalmic or parenteral use) Oxymetazoline and its salts (in nasal preparations for paediatric use) Phenol (preparations with concentration of more than 20%) Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
Phenylephrine and its salts and preparations (in nasal preparations in concentrations of 2.5% or less, for paediatric use) Phenylpropanolamine, its salts and preparations (in preparations containing more than 50 mg per single dose of an immediate release preparation, or more than 75 mg per single dose of a controlled or sustained release preparation, or preparations for which the recommended total daily dose is greater than 150 mg) Physostigmine salicylate (for oral or topical use) Potassium salts (in oral preparations containing more than 5 mmol per single dose) Povidone - iodine (vaginal preparations, except in concentrations of 5% or less) Pramoxine and its salts (for ophthalmic or parenteral use) Prilocaine and its salts (for ophthalmic or parenteral use) Procaine and its salts (for ophthalmic or parenteral use) Promethazine and its salts (except for topical use) Proparacaine and its salts (for ophthalmic or parenteral use) Pseudoephedrine and its salts and preparations as a single entity Salicylic acid and its salts (in topical preparations in concentrations over 40%) Administrative Bylaws of the Saskatchewan College of Pharmacists
Drug Schedules
Sodium chloride (single ingredient solutions in concentrations of more than 0.9%) Sodium picosulphate for oral purgatives, 10 mg per pack (when found in preparations with magnesium oxide 3.5 g and citric acid 12 g) Stramonium, its preparations, extracts and compounds Strontium and its salts (for parenteral use) Tetracaine and its salts (for ophthalmic or parenteral use) Tetrahydrozoline (in nasal preparations for paediatric use) Urea (topical preparations in concentrations of more than 25%) Vaccines: Diphtheria toxoid, Tetanus toxoid, Pertussis, Poliomyelitis, Haemophilus influenzae type B., Measles, Mumps, Pneumococcus, Rubella, Hepatitis B. Pediatric, Influenza cholera vaccine (oral inactivated) when used for prophylaxis against travelers diarrhea and due to enterotoxigenic escherichia coli (ETEC); and – those requiring special enhanced public access due to disease outbreaks; Meningococcus). Vitamins (any parenterals not otherwise scheduled in Schedule I) Xylometazoline and its salts (in nasal preparations for paediatric use)

Source: http://www.napra.ca/Content_Files/Files/Saskatchewan/Legislation/Bylaws-Administrative-Sched-I-II-Mar2011.pdf